Document:

Manufacturing Services Agreement

 EXHIBIT 10.9 
 Manufacturing Services Agreement 
 This
Manufacturing Services Agreement (“Agreement”) effective as of April 16th 2010. 
 Between ONCORE Manufacturing LLC, a Delaware USA company, with its
registered office at 2243 Lundy Ave, San Jose Ca 95131 (“ONCORE”) and Zeltiq Aesthetics with its registered office at 4698 Willow Road, Pleasanton, CA 94588 (“ZELTIQ”) 

Where appropriate, ZELTIQ and ONCORE are hereinafter collectively referred to as “Parties” and individually referred to as
“a Party” 
 Whereas, ZELTIQ is in the business of the development of non-invasive procedures for the reduction of
unwanted fat tissue and requires production and assembly of PCBA (Printed Circuit Board Assemblies) and System Integration 

Whereas ONCORE is in the business of contract manufacturing and provider of electronic manufacturing services 

Whereas, ZELTIQ wishes to engage ONCORE to manufacture the ZELTIQ Control Unit. 

Now therefore, the Parties agree as follows: 

 1 Purpose 
 1.1 This Agreement shall cover the sale of Products by ONCORE to ZELTIQ Products are described in accordance with IPC Standards and Product Parts as defined in the Purchase Order by ZELTIQ.

 2 Forecasts 

2.1 Periodically (but do less frequently than monthly), ZELTIQ deliver to ONCORE (via e-mail or other mutually agreed upon manner)
a Forecast. This Forecast will indicate volumes and the requested delivery date of the manufactured Products for the next 12 months period and is intended to assist ONCORE in planning and Component management purposes. 

2.2 ONCORE shall endeavor to maintain sufficient manufacturing capacity to permit it to deliver the Products to the ZELTIQ in
accordance with the applicable Purchase Orders. 
 3 Purchase Orders 

3.1 ZELTIQ will provide to ONCORE binding Purchase Orders taking into account a lead-time of 16 weeks. 

3.2 ONCORE shall not unreasonably refuse acceptance of any Purchase Order. 

3.3 ZELTIQ may issue Purchase Orders for Production in excess of the Forecast, which will be accepted by ONCORE, provided that
ONCORE can obtain the necessary Components. In the event ONCORE’s Component unavailability prevents ONCORE from committing to the requested delivery date, ONCORE will provide notice to ZELTIQ within ten (10) business days and at that time
the parties will mutually agree on a revised delivery date. If ONCORE does not provide such notice within ten (10) business days then the applicable Purchase Order will be deemed accepted. 

3.4 ZELTIQ may increase, reschedule, or cancel the quantity of any Products specified in a Purchase Order by delivering to ONCORE,
by email, mail or facsimile a written Change Order. No Change Order shall be effective until it is actually received and accepted by ONCORE’s authorized representative. Receipt notice and acceptance (or rejection regarding an increase, due to
ONCORE’s inability to obtain the necessary Components) shall be provided to ZELTIQ within ten (10) business days. If ONCORE does not provide such notice within ten (10) business days then the applicable Purchase Order will be deemed
accepted. 
 3.5 ZELTIQ agrees it is liable to take title to and pay for all quantities of Products reflected on ZELTIQ
Purchase Orders; unless a Change Order has been forwarded by ZELTIQ and accepted by ONCORE. At time of acceptance the Change order shall govern. 
 3.6 ZELTIQ may reschedule once per month, a percentage of Products on a purchase order (as such percentage is specified below) by delivering to ONCORE a Change Order,

  
 2 

 
which is actually received and accepted by an authorized representative of ONCORE, within the number of days as specified below; provided, however, that in no event shall ZELTIQ reschedule any
such installment more than one time or for a period of greater than 90 days: 
  

					
	Shipment	  	 Number of Working Days

Advance Notice

Rescheduled
	  	 Percentage of Scheduled
 That May Be

		  	0-30 days	  	0%
		  	31-60 days	  	Up to 25%
		  	61-90 days	  	Up to 50%
		  	91 or more days	  	Up to 100%

 3.7 In the event that ONCORE purchases and receives material for Purchase Orders accepted by
ONCORE hereunder, and ZELTIQ requests and ONCORE agrees to cancellation or rescheduling of such Purchase Order other than in accordance with Section 3.6, then ONCORE shall notify ZELTIQ of (i) the cost of the relevant materials including
raw materials, work in process, finished goods, excess and obsolete materials that ONCORE has obtained specifically to fulfill ZELTIQ Purchase Orders and cannot use because of such cancellation or rescheduling (collectively referred to as
“Inventories”) and (ii) the cost of the Inventories. 
 3.8 After receiving the cost of the
Inventories from ONCORE pursuant to Section 3.7 with respect to a cancelled or rescheduled Purchase Order, if ZELTIQ elects to continue with the applicable cancellation or rescheduling then ZELTIQ agrees it is responsible for all costs and
expenses and the stated cost of the Inventories associated with the changes, cancellation or rescheduling of such Purchase Order. 
 3.9 In the event of a cancellation of a Purchase Order as described in Section 3.7 all Inventories including but not limited to completed Products, assemblies in process, components and any
tooling, test and burn-in equipment owned by ZELTIQ and furnished to ONCORE, shall be disposed of or handled at ZELTIQ’s expense in accordance with written instructions furnished by the ZELTIQ. 

3.10 Purchase Obligation. All quantities are as set forth in the Purchase Order or by separate written agreement. ZELTIQ
agrees to purchase all Inventories including excess inventory that ONCORE has obtained or manufactured specifically to fulfill ZELTIQ orders (including, without limitation, all non-returnable minimum purchase quantities, tape and reel, tube and tray
items, and all customized non-returnable items) (the “Excess Inventory”) upon receipt of an invoice from ONCORE. 
 ONCORE will provide to ZELTIQ on a monthly basis a report of all Inventories including excess inventory that ONCORE has obtained or manufactured specifically to fulfill ZELTIQ orders. 

4. Delivery & Shipping 
 4.1 Acceptance Testing. ZELTIQ will have the right but not the obligation to conduct or have conducted acceptance testing on all Product deliveries. Within ten

  
 3 

 
(10) business days after ZELTIQ’s receipt of the Product, ZELTIQ will provide ONCORE with a written statement detailing the manner in which the Product has failed to conform to this
Agreement and mutually agreed specifications (which specifications include IPC Standards. ZELTIQ’s failure to so notify ONCORE within such time period shall constitute acceptance of the Products. If the Product delivered hereunder fails to
conform to the Agreement, the mutually agreed specifications, or to such other testing and acceptance criteria as may be mutually agreed upon by the parties in writing (collectively, “Specifications”), ZELTIQ shall notify ONCORE in writing
of such failure, detailing the nature of the alleged failure, and the parties will promptly discuss means to resolve any such failure. ONCORE shall then deliver to ZELTIQ, pursuant to an agreed-upon schedule, but in no event in greater than fifteen
(15) business days after (i) ZELTIQ’s notice of the failure, or (ii) if ZELTIQ is required to provide the components necessary to make the Product after ZELTIQ has provided ONCORE with the component materials required to
manufacture the Products, Products that conform to the Specifications. Upon re-delivery, ZELTIQ shall have an additional ten (10) business day period to conduct acceptance testing on the applicable Product and provide a written statement
detailing the manner in which the Product has failed to conform to the Specifications. 
 4.2 Delivery. Products are
deemed accepted by ZELTIQ AS SPECIFIED in Section 4.1. No returns may be made for any REASON WITHOUT A Returned Material Authorization (“RMA”) number issued by ONCORE provided that ONCORE shall issue RMA numbers for Products eligible
for return under Section 4.1 of Section 6. If ONCORE fails to meet the delivery date specified on a Purchase Order accepted by ONCORE, then ONCORE shall ship the applicable Products via express delivery and be responsible for paying any
express delivery rates applicable to shipment of the Products at issue. 
 4.3 Shipping Terms. In the absence of prior
agreement as to shipping, ONCORE may select a carrier. Shipping terms are F.O.B.: ONCORE Shipping Point. ONCORE’ responsibility for any loss or damage ends, and title passes, when products are delivered to the carrier, to ZELTIQ, or to
ZELTIQ’s agent, whichever occurs first. ZELTIQ will pay for storage charges if products are held by ONCORE at ZELTIQ’s request pending instructions or rescheduled delivery 
 5.0 Prices – Invoicing - Payment Terms 
 5.1
Pricing Terms. Pricing is based on kit quantities as quoted to ZELTIQ, which may be updated and amended from time to time upon written agreement of the parties. If ZELTIQ requires ONCORE to purchase components for the Products from vendors on an
Authorized Vendor List (“AVL”) specified by ZELTIQ, all price increases with respect to the components purchased from vendors on the AVL are the responsibility of ZELTIQ and ZELTIQ agrees to pay for any such increases upon thirty
(30) days prior written notice from ONCORE. Prices do not include any taxes, freight, handling, duty or other charges, payment of which will be the sole responsibility of ZELTIQ. ZELTIQ agrees to assume all tooling costs and expenses that are
pre-approved by ZELTIQ and unique to the assembly or testing of ZELTIQ’s products. Prices are conditioned upon timely payment and any past due balance will accrue interest at the monthly rate of one and one-half percent (1 1/2%). 

  
 4 

 5.2 Payment Terms. Terms of payment arc net 30 days from invoice date to be paid by
way of electronic transfer. All pre-approved non-recurring engineering charges are payable upon receipt of invoice. ONCORE reserves the tight to modify payment terms prior to shipment require payment in advance or delay or cancel any shipment or
order by reason of ZELTIQ’s creditworthiness or should ZELTIQ fail to fulfill any material obligation when due. 
 6 Warranties

 6.1 Performance Warranty. ONCORE warrants that those Products assembled or customized by it shall be free from defects
caused solely by faulty assembly or customization and shall conform to the Specifications for 360 days after delivery. ONCORE confirms that its workmanship complies with IPC 610-A Class 2 Revision B standards and the parties agree that this shall be
the standard for measuring ONCORE’s workmanship. All other products and the components and materials utilized in any assembled or customized products in each case ZELTIQ requires ONCORE to purchase from the ALV unless otherwise instructed in
writing by ZELTIQ and agreed to by ONCORE, are covered by, and subject to, the terms, conditions, and limitations of the manufacturer’s standards warranty which warranty is expressly in lieu of any other warranty, express or implied, of or by
ONCORE or the manufacturer. ZELTIQ’s exclusive remedy, if any, under these warranties is limited, at ONCORE’s election, to any one of (a) refund of ZELTIQ’s purchase price, (b) repair by ONCORE or the manufacturer of any
Products found to be defective, or (c) replacement of any such Product. ZELTIQ acknowledges that except as specifically set forth or referenced in this paragraph. THERE ARE NO REPRESENTATIONS OR WARRANTIES OF ANY KIND (INCLUDING, WITHOUT
LIMITATION, IN ADVERTISING MATERIALS, BROCHURES, OR OTHER DESCRIPTIVE LITERATURE) BY ONCORE OR ANY OTHER PERSON, EXPRESS OR IMPLIED, AS TO THE CONDITION OR PERFORMANCE OF ANY PRODUCTS, THEIR MECHANEABILITY, OR FITNESS FOR A PARTICULAR PURPOSE, OR
OTHERWISE. ONCORE ASSUMES NO RESPONSIBILITY OR LIABILITY WHATSOVER FOR MANUFACTURER’S PRODUCT SPECIFICATIONS OR THE PERFORMANCE OR ADEQUACY OF ANY DESIGN OR SPECIFICATION PROVIDED TO ONCORE BY OR ON BEHALF OF ZELTIQ. 

6.2 Compliance with Laws. ONCORE represents and warrants that ONCORE complies with all applicable laws, rules, regulations, health
and safety requirements as it applies to the assembly of the Products. 
 6.3 SITE AUDITS 

ONCORE will allow ZELTIQ to perform quality assurance inspections and audits of ONCORE’s facility(ies) during regular
business hours upon five (5) business days advance written notice to ONCORE. ONCORE will cooperate with ZELTIQ inspector and will provide ZELTIQ access to ONCORE’s files (electronic or paper) to properly perform any such
inspection or audit. The audit may include records relating to manufacturing compliance with the applicable Specifications, compliance with quality control and, inspection reports procedures, design history requirements, compliance with US FDA

  
 5 

 
GMP/QSR Regulations, regulatory compliance, CE mark certification records and procedures, and compliance with ISO and/or EN requirements as applicable. 

6.4 No Liens, Claims or Encumbrances. ONCORE represents and warrants to ZELTIQ that at the time of delivery to ZELTIQ all Products shall
be free of any securities interest or any other hen, claim or other encumbrance whatsoever. 
 7. Period Termination 

7.1 This Agreement shall commence on the Effective Date for an indefinite term. Beginning eighteen (18) months after the Effective
Date, either party may terminate the Agreement for any reason by giving six (6) months advance written notice. In the event of a termination by ONCORE for reasons of convenience, ONCORE agrees to satisfy and fulfill Purchase Orders accepted
prior to the termination date and agrees to reasonably commercially support ZELTIQ transition to alternative sources. In the event of a termination by ZELTIQ for reasons of convenience, ZELTIQ agrees to pay ONCORE for all finished goods that are
subject to accepted Purchase Orders (“Finished Goods”), work in process (“WIP”), raw materials (“Raw Materials”), open orders with vendors (“Supply”), and Excess Inventory, in each
case, that ONCORE has obtained or manufactured specifically to fulfill ZELTIQ orders and that ONCORE cannot deploy after such termination the amount of such payment being the (“ZELTIQ Expense”). The ZELTIQ Expense shall be
determined by ONCORE based upon (a) the prices for Finished Goods set forth in the relevant Purchase Orders and (b) the cost of WIP, Raw Materials, Supply, and Excess Inventory plus a 15% handling charge. At ONCORE option, ONCORE will
either ship the Finished Goods, WIP, Raw Materials, Supply and Excess Inventory to ZELTIQ upon receipt of full payment of the ZELTIQ Expense or on a COD basis. ONCORE reserves the right to charge ZELTIQ on a monthly inventory holding fee of 2% of
the ZELTIQ Expense. ZELTIQ shall provide ZELTIQ an itemized invoice that details the cost of each element of the ZELTIQ Expense. 
 7.2 A Party may terminate this Agreement for cause if the other Party materially breaches this Agreement and does not cure such breach within thirty (30) days after the breaching Party receives
notice of the breach from the non-breaching Party. 
 7.3 For the sake of clarity, Zeltiq under any circumstances is responsible
for Inventories as defined in 3.7 of this Agreement. 
 8 Confidentiality 

8.1 “Confidential Information” shall mean non-public information that is disclosed by either party to the other
party pursuant to this Agreement, including product specifications and technical and other documentation, business and product plans and other confidential business information whether in written, graphic, electronic or oral form. Confidential
Information shall not include information which: (i) is or becomes public knowledge without any action by, or involvement of, the receiving party; (ii) is disclosed by the receiving party with the specific, prior written approval of the
disclosing party; (iii) is independently developed by the receiving Party without use of the disclosing party’s 

  
 6 

 
Confidential Information; or (iv) is rightfully received by the. receiving party from a third party without a duty of confidentiality. 

8.2 Nondisclosure. All Confidential Information exchanged between ONCORE and ZELTIQ pursuant to this Agreement shall be maintained
as confidential and shall not be distributed, disclosed, or disseminated in any way or form by the receiving party to anyone except its own employees and agents who have a reasonable need to know such Confidential Information and who have been
advised of the confidential nature and required to observe the terms and conditions hereof; nor shall Confidential Information be used by the receiving party for any purpose other than exercising its rights or fulfilling its obligations under this
Agreement. 
 8.3 Legal Obligation to Disclose. This Agreement will not prevent the receiving party from disclosing
Confidential Information of the disclosing party to the extent required by a judicial order or other legal obligation, provided that, in such event, the receiving party shall promptly notify the disclosing party prior to disclosure to allow
intervention, notify the requesting entity of the confidentiality of the materials, and cooperate with the disclosing party to contest or minimize the scope of the disclosure (including application for a protective order). 

8.4 Return of Confidential Information. Upon request of the disclosing party, copies and embodiments of the disclosing
party’s Confidential Information shall be promptly returned to the disclosing party by the receiving party. Upon termination of this Agreement, for any reason, each party shall promptly return to the other party all Confidential Information
provided by the other party, including all copies thereof. 
 9 INDEMNIFICATION. 

ONCORE shall, at its expense, defend, indemnify and hold ZELTIQ and its officers directors, employees and agents harmless from and
against any liabilities, losses, damages, costs and expenses, including, without limitation, reasonable attorneys’ fees, arising from or related to any third party claim, action, suit or proceeding (“Claim”) arising from the
following: (i) from the failure or alleged failure of the Products to comply with the mutually agreed in writing Specifications that are a result of improper assembly; or (ii) alleging that ONCORE’S manufacturing processes infringe
any third party Intellectual Property Rights not specified by ZELTIQ. ZELTIQ will promptly notify ONCORE in writing of any such Claims and give ONCORE control over the defense or settlement of such Claims, provided, however, that (a) the
failure to provide prompt notice shall not relieve ONCORE of its indemnity obligations hereunder except to the extent that the delay in providing notice prejudices the defense of such Claims, and (b) ZELTIQ shall have the right to participate
in the defense of such Claims at its expense. ONCORE shall not settle, or consent to any entry of judgment with respect to, any such Claims without obtaining either (x) an unconditional release of ZELTIQ (and its officers, directors, employees
and agents) from all liability with respect to such Claims, or (y) the prior written consent of ZELTIQ. ZELTIQ will make available to ONCORE any books or records in ZELTIQ’s possession that are necessary to the defense of any such Claims.

  
 7 

 10. LIMITED LIABILITY. EXCEPT FOR ANY
AMOUNTS REQUIRED PURSUANT TO THE OBLIGATIONS OF INDEMNIFICATION HEREUNDER OR DAMAGES ARISING FROM A BREACH BY A PARTY OF SECTION 8, NEITHER PARTY WILL BE LIABLE TO THE OTHER PARTY FOR ANY LOST PROFITS OR FOR ANY CONSEQUENTIAL, SPECIAL OR INCIDENTAL
DAMAGES SUFFERED BY THE OTHER PARTY ARISING OUT OF OR RELATED TO THIS AGREEMENT. 
 11 Insurance. ONCORE shall maintain,
during the term of the Agreement and for one (1) year thereafter, (i) a general liability insurance policy with coverage for Completed Products, issued by an insurer with an “A” rating, which shall name ZELTIQ, including any
parent company, subsidiaries, affiliates, owners, stockholders, directors, officers, employees, agents, representatives, heirs, successors, and assigns (the “Insured Parties”) as additional insureds against any and all demands,
claims, suits, causes of action, whether at law or in equity, and/or liability to anyone for any injuries to their person, or property, arising out of a defect in the Products (the “Product Liability Policy”); and (ii) a
property insurance policy, issued by an insurer with an “A” rating, which shall name the Insured Parties as additional Loss Payees to cover the loss, destruction or theft of any of the ZELTIQ materials (the policies collectively referred
to as the “Manufacturer Policies”). The coverage for the Product Liability Policy shall be not less than one million dollars ($1,000,000.00) per occurrence, combined single-limit bodily injury and property damage, and not less than
two million dollars ($2,000,000.00) in the aggregate. ONCORE Policies shall provide for not less than thirty (30) days advance written notice to ZELTIQ of a cancellation or termination of the ONCORE Policies, of a reduction of ONCORE
Policies’ limits, or of any other material change in ONCORE Policies. Within thirty (30) days after the execution of this Agreement, ONCORE shall deliver to ZELTIQ a certificate of insurance confirming the existence or issuance of the
ONCORE Policies. 
 12 Construction. Any addition or change to the terms of this Agreement must be specifically agreed to
in writing by a duly authorized officer of ONCORE and ZELTIQ before becoming binding. In the event of any conflict between the terms of this Agreement and the terms of the Purchase Order, the terms of this Agreement shall govern. 

13 Force Majeure 

ONCORE will not be liable for any failure or delay in its performance or in the delivery or shipment of product, or for any damages
suffered by ZELTIQ by reason of such failure or delay, when such failure or delay is caused by, or arises in connection with, any fire, flood, accident, riot, earthquake, severe weather, war, governmental interference or embargo, strike, shortage of
labor, fuel, power, or any other cause or causes beyond ONCORE’ reasonable control. Each Party reserves the right to cancel without liability any order, with the exception of Section 3.10, the shipment of which is or may be delayed for
more than 30 days by reason of any such cause ONCORE reserves the right to allocate in its sole discretion among ZELTIQ’S or potential ZELTIQ’s or defer or delay the shipment of, any product which is in short supply. 

  
 8 

 14 Survival 
 The rights and obligations of the parties hereto under the provisions of Confidentiality (Section 8) and the Nondisclosure Agreement dated August 28, 2008 shall survive expiration or termination of
this Agreement and shall remain in full force and effect for a period of live (5) years following the expiration or termination of this Agreement. 
 15 Governing Law – Jurisdiction 
 This Agreement shall in all respects
be governed by the law of California USA. 
 16 Severability. If for any reason a court of competent jurisdiction finds any
provision of this Agreement to be unenforceable, that provision of the Agreement shall be enforced to the maximum extent permissible so as to effect the intent of the parties, and the remainder of this Agreement will continue in full force and
effect. 
 17 Relationship of the Parties. Neither execution nor performance of this Agreement will be construed to have
established any agency, joint venture, or partnership relationship between the parties. 
 18 Enforceable Contract.
ZELTIQ acknowledges and represents that it is a sophisticated party in the Medical Device manufacturing industry, that it has read and understood all of the terms and conditions of this Agreement and understands and agrees that this Agreement
constitutes a legally enforceable contract. 
  

									
	ONCORE	 		 	ZELTIQ
					
	By:	 	/s/ Brad Tesch	 		 	By:	 	/s/ John Howe
	Title:	 	SVP Sales	 		 	Title:	 	CFO
	Name:	 	Brad Tesch	 		 	Name:	 	John Howe

  
 92005 Stock Incentive Plan

 EXHIBIT 10.11 
 ZELTIQ AESTHETICS, INC. 
 2005 STOCK INCENTIVE PLAN 

 

	1.	Purpose 

 The purpose of
this 2005 Stock Incentive Plan (the “Plan”) of Zeltiq Aesthetics, Inc., a Delaware corporation (the “Company”), is to advance the interests of the Company’s stockholders by enhancing the Company’s ability to
attract, retain and motivate persons who are expected to make important contributions to the Company and by providing such persons with equity ownership opportunities and performance-based incentives that are intended to align their interests with
those of the Company’s stockholders. Except where the context otherwise requires, the term “Company” shall include any of the Company’s present or future parent or subsidiary corporations as defined in Sections 424(e) or
(f) of the Internal Revenue Code of 1986, as amended, and any regulations promulgated thereunder (the “Code”) and any other business venture (including, without limitation, joint venture or limited liability company) in which the
Company has a controlling interest, as determined by the Board of Directors of the Company (the “Board”). 
  

	2.	Eligibility 

 All of the
Company’s employees, officers, directors, consultants and advisors are eligible to receive options, restricted stock, restricted stock units and other stock-based awards (each, an “Award”) under the Plan; provided, however, that
Incentive Stock Options (as hereinafter defined) shall only be granted to employees of the Company, any of the Company’s present or future parent or subsidiary corporations, and any other entities the employees of which are eligible to receive
Incentive Stock Options under the Code. Each person who receives an Award under the Plan is deemed a “Participant”. 
  

	3.	Administration and Delegation 

 (a) Administration by Board of Directors. The Plan will be administered by the Board. The Board shall have authority to grant Awards and to adopt, amend and repeal such administrative rules,
guidelines and practices relating to the Plan as it shall deem advisable. The Board may correct any defect, supply any omission or reconcile any inconsistency in the Plan or any Award in the manner and to the extent it shall deem expedient to carry
the Plan into effect and it shall be the sole and final judge of such expediency. All decisions by the Board shall be made in the Board’s sole discretion and shall be final and binding on all persons having or claiming any interest in the Plan
or in any Award. No director or person acting pursuant to the authority delegated by the Board shall be liable for any action or determination relating to or under the Plan made in good faith. 

(b) Appointment of Committees. To the extent permitted by applicable law, the Board may delegate any or all of its powers under
the Plan to one or more committees or subcommittees of the Board (a “Committee”). All references in the Plan to the “Board” shall mean the Board or a Committee or the officers referred to in Section 3(c) to the extent that
the Board’s powers or authority under the Plan have been delegated to such Committee or officers. 

 (c) Delegation to Officers. To the extent permitted by applicable law, the Board may
delegate to one or more officers of the Company the power to grant Awards to employees or officers of the Company or any of its present or future subsidiary corporations and to exercise such other powers under the Plan as the Board may determine;
provided that the Board shall fix the terms of the Awards to be granted by such officers (including the exercise price of such Awards, which may include a formula by which the exercise price will be determined) and the maximum number of shares
subject to Awards that the officers may grant; provided, however, that no officer shall be authorized to grant Awards to any “executive officer” of the Company (as defined by Rule 3b-7 under the Securities Exchange Act of 1934, as amended
(the “Exchange Act”)) or to any “officer” of the Company (as defined by Rule 16a-1 under the Exchange Act). 
  

	4.	Stock Available for Awards 

Subject to adjustment under Section 8, Awards may be made under the Plan for up to 1,000,000 shares of common stock, $.001 par
value per share, of the Company (the “Common Stock”). If any Award expires or is terminated, surrendered or canceled without having been fully exercised or is forfeited in whole or in part (including as the result of shares of Common Stock
subject to such Award being repurchased by the Company at the original issuance price pursuant to a contractual repurchase right) or results in any Common Stock not being issued, the unused Common Stock covered by such Award shall again be available
for the grant of Awards under the Plan. Further, shares of Common Stock tendered to the Company by a Participant to exercise an Award shall be added to the number of shares of Common Stock available for the grant of Awards under the Plan. However,
in the case of Incentive Stock Options, the foregoing provisions shall be subject to any limitations under the Code. Shares issued under the Plan may consist in whole or in part of authorized but unissued shares or treasury shares. At no time while
there is any Option (as defined below) outstanding and held by a Participant who was a resident of the State of California on the date of grant of such Option, shall the total number of shares of Common Stock issuable upon exercise of all
outstanding options and the total number of shares provided for under any stock bonus or similar plan of the Company exceed the applicable percentage as calculated in accordance with the conditions and exclusions of Section 260.140.45 of the
California Code of Regulations (the “California Regulations”), based on the shares of the Company which are outstanding at the time the calculation is made. 
  

	5.	Stock Options 

 (a)
General. The Board may grant options to purchase Common Stock (each, an “Option”) and determine the number of shares of Common Stock to be covered by each Option, the exercise price of each Option and the conditions and limitations
applicable to the exercise of each Option, including conditions relating to applicable federal or state securities laws, as it considers necessary or advisable. An Option which is not intended to be an Incentive Stock Option shall be designated a
“Nonstatutory Stock Option”. 
 (b) Incentive Stock Options. An Option that the Board intends to be an
“incentive stock option” as defined in Section 422 of the Code (an “Incentive Stock Option”) shall only be granted to employees of the Company, any of the Company’s present or future parent or subsidiary corporations as
defined in Sections 424(e) or (f) of the Code, and any other entities the employees of which are eligible to receive Incentive Stock Options under the Code, and shall 

  
 - 2 -

 
be subject to and shall be construed consistently with the requirements of Section 422 of the Code. The Company shall have no liability to a Participant, or any other party, if an Option (or
any part thereof) that is intended to be an Incentive Stock Option is not an Incentive Stock Option or for any action taken by the Board pursuant to Section 9(f), including without limitation the conversion of an Incentive Stock Option to a
Nonstatutory Stock Option. The terms of any Incentive Stock Options granted pursuant to the Plan must comply with the following additional provisions of this Section 5(b). 

(1) Exercise Price. The exercise price per share of Common Stock shall be set by the Committee; provided that the
exercise price for any Incentive Stock Options shall not be less than 100% of the Fair Market Value (as hereinafter defined) on the date of grant. 
 (2) Expiration of Option. An Incentive Stock Option may not be exercised to any extent by anyone after the first to occur of the following events: 

 

	 	(i)	Ten years from the date it is granted, unless an earlier time is set in the Award agreement. 

 

	 	(ii)	One year after the date of the Participant’s termination of employment or service on account of disability or death. Upon the Participant’s disability or
death, any Incentive Stock Options exercisable at the Participant’s disability or death may be exercised by the Participant’s legal representative or representatives, by the person or persons entitled to do so pursuant to the
Participant’s last will and testament, or, if the Participant fails to make testamentary disposition of such Incentive Stock Option or dies intestate, by the person or persons entitled to receive the Incentive Stock Option pursuant to the
applicable laws of descent and distribution. 

  

	 	(iii)	Three months after the date of the Participant’s termination of employment or service for any reason other than disability or death. 

(3) Individual Dollar Limitation. The aggregate Fair Market Value (determined as of the time the Option is granted)
of all shares of Common Stock with respect to which Incentive Stock Options are first exercisable by a Participant in any calendar year may not exceed $100,000.00 or such other limitation as imposed by Section 422(d) of the Code, or any
successor provision. To the extent that Incentive Stock Options are first exercisable by a Participant in excess of such limitation, the excess shall be considered Nonstatutory Stock Options. 

(4) Ten Percent Owners. An Incentive Stock Option shall be granted to any individual who, at the date of grant,
owns stock possessing more than 10% of the total combined voting power of all classes of Common Stock only if such Option is granted at a price that is not less than 110% of Fair Market Value on the date of grant and the Option is exercisable for no
more than five years from the date of grant. 

  
 - 3 -

 (5) Transfer Restriction. The Participant shall give the Company
prompt notice of any disposition of shares of Common Stock acquired by exercise of an Incentive Stock Option within (i) two years from the date of grant of such Incentive Stock Option or (ii) one year after the transfer of such shares of
Common Stock to the Participant. 
 (6) Expiration of Incentive Stock Options. No Award of an Incentive
Stock Option may be made pursuant to the Plan after the tenth anniversary of the date on which the Plan is adopted by the Board, or the date the Plan was approved by the Company’s stockholders, which is earlier. 

(7) Right to Exercise. During a Participant’s lifetime, an Incentive Stock Option may be exercised only by the
Participant. 
 (c) Exercise Price. Except as otherwise provided in the Zeltiq Aesthetics, Inc. 2005 Stock Incentive
Plan California Supplement, the Board shall establish the exercise price of each Option and specify such exercise price in the applicable option agreement. 
 (d) Duration of Options. Except as otherwise provided in the Zeltiq Aesthetics, Inc. 2005 Stock Incentive Plan California Supplement, each Option shall be exercisable at such times and subject
to such terms and conditions as the Board may specify in the applicable option agreement. 
 (e) Exercise of Option.
Options may be exercised by delivery to the Company of a written notice of exercise signed by the proper person or by any other form of notice (including electronic notice) approved by the Board together with payment in full as specified in
Section 5(f) for the number of shares for which the Option is exercised. Shares of Common Stock subject to the Option will be delivered by the Company following exercise as soon as practicable. 

(f) Payment Upon Exercise. Common Stock purchased upon the exercise of an Option granted under the Plan shall be paid for as
follows: 
 (1) in cash or by check, payable to the order of the Company; 

(2) except as the Board may otherwise provide in an option agreement, by (i) delivery of an irrevocable and
unconditional undertaking by a creditworthy broker to deliver promptly to the Company sufficient funds to pay the exercise price and any required tax withholding or (ii) delivery by the Participant to the Company of a copy of irrevocable and
unconditional instructions to a creditworthy broker to deliver promptly to the Company cash or a check sufficient to pay the exercise price and any required tax withholding; 

(3) when the Common Stock is registered under the Exchange Act, by delivery of shares of Common Stock owned by the
Participant valued at their fair market value as determined by (or in a manner approved by) the Board (“Fair Market Value”); provided (i) such method of payment is then permitted under applicable law, (ii) such Common Stock, if
acquired directly from the Company, was owned by the Participant for such minimum period of time, if any, as may be established by the Board in its discretion and (iii) such Common Stock is not subject to any repurchase, forfeiture, unfulfilled
vesting or other similar requirements; 

  
 - 4 -

 (4) to the extent permitted by applicable law and by the Board, by
(i) delivery of a promissory note of the Participant to the Company on terms determined by the Board, or (ii) payment of such other lawful consideration as the Board may determine; or 

(5) by any combination of the above permitted forms of payment. 

Notwithstanding any other provision of the Plan to the contrary, no Participant who is a member of the Board or an
“executive officer” of the Company within the meaning of Section 13(k) of the Exchange Act shall be permitted to pay the exercise price of an Option in any method which would violate Section 13(k) of the Exchange Act. 

(g) Substitute Options. In connection with a merger or consolidation of an entity with the Company or the acquisition by the
Company of property or stock of an entity, the Board may grant Options in substitution for any options or other stock or stock-based awards granted by such entity or an affiliate thereof. Substitute Options may be granted on such terms as the Board
deems appropriate in the circumstances, notwithstanding any limitations on Options contained in the other sections of this Section 5 or in Section 2. Substitute Options shall not count against the overall share limit set forth in
Section 4(a), except as may be required by reason of Section 422 and related provisions of the Code. 
 (h)
Repricing of Options. The Board may, without stockholder approval, amend any outstanding Option granted under the Plan to provide an exercise price per share that is lower than the then-current exercise price per share of such outstanding
Option. The Board may also, without stockholder approval, cancel any outstanding option (whether or not granted under the Plan) and grant in substitution therefor new Awards under the Plan covering the same or a different number of shares of Common
Stock and having an exercise price per share lower than the then-current exercise price per share of the cancelled option. 
  

	6.	Restricted Stock; Restricted Stock Units 

 (a) General. The Board may grant Awards entitling recipients to acquire shares of Common Stock (“Restricted Stock”), subject to the right of the Company to repurchase all or part of such
shares at their issue price or other stated or formula price (or to require forfeiture of such shares if issued at no cost) from the recipient in the event that conditions specified by the Board in the applicable Award are not satisfied prior to the
end of the applicable restriction period or periods established by the Board for such Award. Instead of granting Awards for Restricted Stock, the Board may grant Awards entitling the recipient to receive shares of Common Stock to be delivered at the
time such shares of Common Stock vest (“Restricted Stock Units”) (Restricted Stock and Restricted Stock Units are each referred to herein as a “Restricted Stock Award”). 

(b) Terms and Conditions. The Board shall determine the terms and conditions of a Restricted Stock Award, including the conditions
for repurchase (or forfeiture) and the issue price, if any. 
 (c) Stock Certificates. Any stock certificates issued in
respect of a Restricted Stock Award shall be registered in the name of the Participant, bearing an appropriate legend referring to the terms, conditions, and restrictions applicable to such Restricted Stock Award, and, unless

  
 - 5 -

 
otherwise determined by the Board, deposited by the Participant, together with a stock power endorsed in blank, with the Company (or its designee). At the expiration of the applicable restriction
periods, the Company (or such designee) shall deliver the certificates no longer subject to such restrictions to the Participant or if the Participant has died, to the beneficiary designated, in a manner determined by the Board, by a Participant to
receive amounts due or exercise rights of the Participant in the event of the Participant’s death (the “Designated Beneficiary”). In the absence of an effective designation by a Participant, “Designated Beneficiary” shall
mean the Participant’s estate. 
  

	7.	Other Stock-Based Awards 

Other Awards of shares of Common Stock, and other Awards that are valued in whole or in part by reference to, or are otherwise based on,
shares of Common Stock or other property, may be granted hereunder to Participants (“Other Stock Unit Awards”), including without limitation stock appreciation rights and Awards entitling recipients to receive shares of Common Stock to be
delivered in the future. Such Other Stock Unit Awards shall also be available as a form of payment in the settlement of other Awards granted under the Plan or as payment in lieu of compensation to which a Participant is otherwise entitled. Other
Stock Unit Awards may be paid in shares of Common Stock or cash, as the Board shall determine. Subject to the provisions of the Plan, the Board shall determine the conditions of each Other Stock Unit Award, including any purchase price applicable
thereto. 
  

	8.	Adjustments for Changes in Common Stock and Certain Other Events 

 (a) Changes in Capitalization. In the event of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spin-off or other similar
change in capitalization or event, or any distribution to holders of Common Stock other than an ordinary cash dividend, (i) the number and class of securities available under the Plan, (ii) the number and class of securities and exercise
price per share of each outstanding Option, (iii) the repurchase price per share subject to each outstanding Restricted Stock Award, and (iv) the terms of each other outstanding Award shall be appropriately adjusted by the Company (or
substituted Awards may be made, if applicable) to the extent determined by the Board. 
 (b) Reorganization Events 

(1) Definition. A “Reorganization Event” shall mean: (a) any merger or consolidation of the Company
with or into another entity as a result of which all of the Common Stock of the Company is converted into or exchanged for the right to receive cash, securities or other property or is cancelled, (b) any exchange of all of the Common Stock of
the Company for cash, securities or other property pursuant to a share exchange transaction or (c) any liquidation or dissolution of the Company. 
 (2) Consequences of a Reorganization Event on Awards Other than Restricted Stock Awards. In connection with a Reorganization Event, the Board shall take any one or more of the following actions as
to all or any outstanding Awards on such terms as the Board determines: (i) provide that Awards shall be assumed, or substantially equivalent Awards shall 

  
 - 6 -

 
be substituted, by the acquiring or succeeding corporation (or an affiliate thereof), (ii) upon written notice to a Participant, provide that the Participant’s unexercised Options or
other unexercised Awards shall become exercisable in full and will terminate immediately prior to the consummation of such Reorganization Event unless exercised by the Participant within a specified period following the date of such notice,
(iii) provide that outstanding Awards shall become realizable or deliverable, or restrictions applicable to an Award shall lapse, in whole or in part prior to or upon such Reorganization Event, (iv) in the event of a Reorganization Event
under the terms of which holders of Common Stock will receive upon consummation thereof a cash payment for each share surrendered in the Reorganization Event (the “Acquisition Price”), make or provide for a cash payment to a Participant
equal to (A) the Acquisition Price times the number of shares of Common Stock subject to the Participant’s Options or other Awards (to the extent the exercise price does not exceed the Acquisition Price) minus (B) the aggregate
exercise price of all such outstanding Options or other Awards, in exchange for the termination of such Options or other Awards, (v) provide that, in connection with a liquidation or dissolution of the Company, Awards shall convert into the
right to receive liquidation proceeds (if applicable, net of the exercise price thereof), and (vi) any combination of the foregoing. 
 For purposes of clause (i) above, an Option shall be considered assumed if, following consummation of the Reorganization Event, the Option confers the right to purchase, for each share of Common
Stock subject to the Option immediately prior to the consummation of the Reorganization Event, the consideration (whether cash, securities or other property) received as a result of the Reorganization Event by holders of Common Stock for each share
of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock);
provided, however, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or
succeeding corporation, provide for the consideration to be received upon the exercise of Options to consist solely of common stock of the acquiring or succeeding corporation (or an affiliate thereof) having an equivalent value (as determined by the
Board) to the per share consideration received by holders of outstanding shares of Common Stock as a result of the Reorganization Event. 
 To the extent all or any portion of an Option becomes exercisable solely as a result of clause (ii) above, the Board may provide that upon exercise of such Option the Participant shall receive shares
subject to a right of repurchase by the Company or its successor at the Option exercise price; such repurchase right (x) shall lapse at the same rate as the Option would have become exercisable under its terms and (y) shall not apply to
any shares subject to the Option that were exercisable under its terms without regard to clause (ii) above. 

(3) Consequences of a Reorganization Event on Restricted Stock Awards. Upon the occurrence of a Reorganization
Event other than a liquidation or dissolution of the Company, the repurchase and other rights of the Company under each outstanding Restricted Stock Award shall inure to the benefit of the Company’s successor and shall apply to the cash,
securities or other property which the Common Stock was converted into or exchanged for pursuant to such Reorganization Event in the same manner and to the same extent as they applied to the Common Stock subject to such Restricted Stock Award. Upon
the occurrence of a 

  
 - 7 -

 
Reorganization Event involving the liquidation or dissolution of the Company, except to the extent specifically provided to the contrary in the instrument evidencing any Restricted Stock Award or
any other agreement between a Participant and the Company, all restrictions and conditions on all Restricted Stock Awards then outstanding shall automatically be deemed terminated or satisfied. 

 

	9.	General Provisions Applicable to Awards 

 (a) Transferability of Awards. Except as the Board may otherwise determine or provide in an Award, Awards shall not be sold, assigned, transferred, pledged or otherwise encumbered by the person to
whom they are granted, either voluntarily or by operation of law, except by will or the laws of descent and distribution or, other than in the case of an Incentive Stock Option, pursuant to a qualified domestic relations order, and, during the life
of the Participant, shall be exercisable only by the Participant. References to a Participant, to the extent relevant in the context, shall include references to authorized transferees. 

(b) Documentation. Each Award shall be evidenced in such form (written, electronic or otherwise) as the Board shall determine.
Each Award may contain terms and conditions in addition to those set forth in the Plan. 
 (c) Board Discretion. Except
as otherwise provided by the Plan, each Award may be made alone or in addition or in relation to any other Award. The terms of each Award need not be identical, and the Board need not treat Participants uniformly. 

(d) Termination of Status. The Board shall determine the effect on an Award of the disability, death, retirement, authorized leave
of absence or other change in the employment or other status of a Participant and the extent to which, and the period during which, the Participant, or the Participant’s legal representative, conservator, guardian or Designated Beneficiary, may
exercise rights under the Award. 
 (e) Withholding. Each Participant shall pay to the Company, or make provision
satisfactory to the Company for payment of, any taxes required by law to be withheld in connection with an Award to such Participant. Except as the Board may otherwise provide in an Award, for so long as the Common Stock is registered under the
Exchange Act, Participants may satisfy such tax obligations in whole or in part by delivery of shares of Common Stock, including shares retained from the Award creating the tax obligation, valued at their Fair Market Value; provided, however, except
as otherwise provided by the Board, that the total tax withholding where stock is being used to satisfy such tax obligations cannot exceed the Company’s minimum statutory withholding obligations (based on minimum statutory withholding rates for
federal and state tax purposes, including payroll taxes, that are applicable to such supplemental taxable income). Shares surrendered to satisfy tax withholding requirements cannot be subject to any repurchase, forfeiture, unfulfilled vesting or
other similar requirements. The Company may, to the extent permitted by law, deduct any such tax obligations from any payment of any kind otherwise due to a Participant. 

  
 - 8 -

 (f) Amendment of Award. The Board may amend, modify or terminate any outstanding
Award, including but not limited to, substituting therefor another Award of the same or a different type, [changing the date of exercise or realization,] and converting an Incentive Stock Option to a Nonstatutory Stock Option; provided that the
Participant’s consent to such action shall be required unless the Board determines that the action, taking into account any related action, would not materially and adversely affect the Participant. 

(g) Conditions on Delivery of Stock. The Company will not be obligated to deliver any shares of Common Stock pursuant to the Plan
or to remove restrictions from shares previously delivered under the Plan until (i) all conditions of the Award have been met or removed to the satisfaction of the Company, (ii) in the opinion of the Company’s counsel, all other legal
matters in connection with the issuance and delivery of such shares have been satisfied, including any applicable securities laws and any applicable stock exchange or stock market rules and regulations, and (iii) the Participant has executed
and delivered to the Company such representations or agreements as the Company may consider appropriate to satisfy the requirements of any applicable laws, rules or regulations. 

(h) Acceleration. The Board may at any time provide that any Award shall become immediately exercisable in full or in part, free
of some or all restrictions or conditions, or otherwise realizable in full or in part, as the case may be. 
 (i) Unfunded
Status of Awards. The Plan is intended to be an “unfunded” plan for incentive compensation. With respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in the Plan or any Award agreement shall
give the Participant any rights that are greater than those of a general creditor of the Company or any subsidiary corporations. 
  

	10.	Miscellaneous 

 (a) No
Right To Employment or Other Status. No person shall have any claim or right to be granted an Award, and the grant of an Award shall not be construed as giving a Participant the right to continued employment or any other relationship with the
Company. The Company expressly reserves the right at any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan, except as expressly provided in the applicable Award. 

(b) No Rights As Stockholder. Subject to the provisions of the applicable Award, no Participant or Designated Beneficiary shall
have any rights as a stockholder with respect to any shares of Common Stock to be distributed with respect to an Award until becoming the record holder of such shares. Notwithstanding the foregoing, in the event the Company effects a split of the
Common Stock by means of a stock dividend and the exercise price of and the number of shares subject to such Option are adjusted as of the date of the distribution of the dividend (rather than as of the record date for such dividend), then an
optionee who exercises an Option between the record date and the distribution date for such stock dividend shall be entitled to receive, on the distribution date, the stock dividend with respect to the shares of Common Stock acquired

  
 - 9 -

 
upon such Option exercise, notwithstanding the fact that such shares were not outstanding as of the close of business on the record date for such stock dividend. 

(c) Effective Date and Term of Plan. The Plan shall become effective on the date on which it is adopted by the Board. No Awards
shall be granted under the Plan after the completion of 10 years from the earlier of (i) the date on which the Plan was adopted by the Board or (ii) the date the Plan was approved by the Company’s stockholders, but Awards previously
granted may extend beyond that date. 
 (d) Amendment of Plan. The Board may amend, suspend or terminate the Plan or any
portion thereof at any time. 
 (e) Authorization of Sub-Plans. The Board may from time to time establish one or more
sub-plans under the Plan for purposes of satisfying applicable blue sky, securities or tax laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan containing (i) such limitations on the
Board’s discretion under the Plan as the Board deems necessary or desirable or (ii) such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements adopted by
the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Participants within the affected jurisdiction and the Company shall not be required to provide copies of any supplement to Participants in any jurisdiction
which is not the subject of such supplement. 
 (f) Indemnification. To the extent allowable pursuant to applicable law,
each member of the Committee or of the Board shall be indemnified and held harmless by the Company from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred by such member in connection with or resulting from any
claim, action, suit, or proceeding to which he or she may be a party or in which he or she may be involved by reason of any action or failure to act pursuant to the Plan and against and from any and all amounts paid by him or her in satisfaction of
judgment in such action, suit, or proceeding against him or her; provided he or she gives the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The
foregoing right of indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled pursuant to the Company’s Certificate of Incorporation or Bylaws, as a matter of law, or otherwise, or any
power that the Company may have to indemnify them or hold them harmless. 
 (g) Relationship to Other Benefits. No
payment pursuant to the Plan shall be taken into account in determining any benefits pursuant to any pension, retirement, savings, profit sharing, group insurance, welfare or other benefit plan of the Company except to the extent otherwise expressly
provided in writing in such other plan or an agreement thereunder. 
 (h) Expenses. The expenses of administering the
Plan shall be borne by the Company. 

  
 - 10 -

 (i) Titles and Headings. The titles and headings of the Sections in the Plan are for
convenience of reference only and, in the event of any conflict, the text of the Plan, rather than such titles or headings, shall control. 
 (j) Limitations Applicable to Section 16 Persons. Notwithstanding any other provision of the Plan, the Plan, and any Award granted or awarded to any Participant who is then subject to
Section 16 of the Exchange Act, shall be subject to any additional limitations set forth in any applicable exemptive rule under Section 16 of the Exchange Act (including any amendment to Rule 16b-3 of the Exchange Act) that are
requirements for the application of such exemptive rule. To the extent permitted by applicable law, the Plan and Awards granted or awarded hereunder shall be deemed amended to the extent necessary to conform to such applicable exemptive rule.

 (k) Government and Other Regulations. The obligation of the Company to make payment of awards in Common Stock or
otherwise shall be subject to all applicable laws, rules, and regulations, and to such approvals by government agencies as may be required. The Company shall be under no obligation to register pursuant to the Securities Act of 1933, as amended (the
“Securities Act”), any of the shares of Common Stock paid pursuant to the Plan. If the shares paid pursuant to the Plan may in certain circumstances be exempt from registration pursuant to the Securities Act, the Company may restrict the
transfer of such shares in such manner as it deems advisable to ensure the availability of any such exemption. 
 (l)
Compliance with Code Section 409A. No Award shall provide for deferral of compensation that does not comply with Section 409A of the Code, unless the Board, at the time of grant, specifically provides that the Award is not intended
to comply with Section 409A of the Code. 
 (m) Governing Law. The provisions of the Plan and all Awards made
hereunder shall be governed by and interpreted in accordance with the laws of the State of Delaware, excluding choice-of-law principles of the law of such state that would require the application of the laws of a jurisdiction other than such state.

  
 - 11 -

 ZELTIQ AESTHETICS, INC. 

2005 STOCK INCENTIVE PLAN 
 CALIFORNIA SUPPLEMENT 
 Pursuant to Section 10(e) of the Plan, the
Board has adopted this supplement for purposes of satisfying the requirements of Section 25102(o) of the California Law: 

Any Awards granted under the Plan to a Participant who is a resident of the State of California on the date of grant (a “California
Participant”) shall be subject to the following additional limitations, terms and conditions: 
 1. Additional Limitations on
Options. 
 (a) Minimum Vesting Rate. Except in the case of Options granted to California Participants who are
officers, directors, managers, consultants or advisors of the Company or its affiliates (which Options may become exercisable at whatever rate is determined by the Board), Options granted to California Participants shall become exercisable at a rate
of no less than 20% per year over five years from the date of grant; provided that such Options may be subject to such reasonable forfeiture conditions as the Board may choose to impose and which are not inconsistent with
Section 260.140.41 of the California Regulations. 
 (b) Minimum Exercise Price. The exercise price of Options
granted to California Participants may not be less than 85% of the Fair Market Value of the Common Stock on the date of grant in the case of a Nonstatutory Stock Option or less than 100% of the Fair Market Value of the Common Stock on the date of
grant in the case of an Incentive Stock Option; provided, however, that if the California Participant is a person who owns stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or its parent or
subsidiary corporations, the exercise price shall be not less than 110% of the Fair Market Value of the Common Stock on the date of grant. 
 (c) Maximum Duration of Options. No Options granted to California Participants will be granted for a term in excess of 10 years. 

(d) Minimum Exercise Period Following Termination. Unless a California Participant’s employment is terminated for cause (as
defined in any contract of employment between the Company and such Participant, or if none, in the instrument evidencing the grant of such Participant’s Option), in the event of termination of employment of such Participant, he or she shall
have the right to exercise an Option, to the extent that he or she was otherwise entitled to exercise such Option on the date employment terminated, as follows: (i) at least six months from the date of termination, if termination was caused by
such Participant’s death or “permanent and total disability” (within the meaning of Section 22(e)(3) of the Code) and (ii) at least 30 days from the date of termination, if termination was caused other than by such
Participant’s death or “permanent and total disability” (within the meaning of Section 22(e)(3) of the Code). 

  
 A - 1

 (e) Limitation on Repurchase Rights. If an Option granted to a California
Participant gives the Company the right to repurchase shares of Common Stock issued pursuant to the Plan upon termination of employment of such Participant, the terms of such repurchase right must comply with Section 260.140.41(k) of the
California Regulations. 
 2. Additional Limitations for Restricted Stock Awards. 

(a) Minimum Purchase Price. The purchase price for a Restricted Stock Award granted to a California Participant shall be not less
than 85% of the Fair Market Value of the Common Stock at the time such Participant is granted the right to purchase shares under the Plan or at the time the purchase is consummated; provided, however, that if such Participant is a person who owns
stock possessing more than 10% of the total combined voting power or value of all classes of stock of the Company or its parent or subsidiary corporations, the purchase price shall be not less than 100% of the Fair Market Value of the Common Stock
at the time such Participant is granted the right to purchase shares under the Plan or at the time the purchase is consummated. 

(b) Limitation of Repurchase Rights. If a Restricted Stock Award granted to a California Participant gives the Company the right
to repurchase shares of Common Stock issued pursuant to the Plan upon termination of employment of such Participant, the terms of such repurchase right must comply with Section 260.140.42(h) of the California Regulations. 

3. Additional Limitations for Other Stock-Based Awards. The terms of all Awards granted to a California Participant under Section 7 of the
Plan shall comply, to the extent applicable, with Section 260.140.41 or Section 260.140.42 of the California Regulations. 
 4.
Additional Requirement to Provide Information to California Participants. The Company shall provide to each California Participant and to each California Participant who acquires Common Stock pursuant to the Plan, not less frequently than
annually, copies of annual financial statements (which need not be audited). The Company shall not be required to provide such statements to key employees whose duties in connection with the Company assure their access to equivalent information.

 5. Additional Limitations on Timing of Awards. No Award granted to a California Participant shall become exercisable, vested or
realizable, as applicable to such Award, unless the Plan has been approved by a majority of the Company’s stockholders within 12 months before or after the date the Plan was adopted by the Board. 

6. Additional Limitations Relating to Definition of Fair Market Value. For purposes of Section 1(b) and 2(a) of this supplement, “Fair
Market Value” shall be determined in a manner not inconsistent with Section 260.140.50 of the California Regulations. 
 7.
Additional Restriction Regarding Recapitalizations, Stock Splits, Etc. For purposes of Section 8 of the Plan, in the event of a stock split, reverse stock split, stock dividend, recapitalization, combination, reclassification or other
distribution of the Company’s securities, the number of securities allocated to each California Participant must be adjusted proportionately and without the receipt by the Company of any consideration from any California Participant.

  
 A - 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00193-of-00352.parquet"}]]